ScienceAustralia1 sourcesNeutral

Seaport Therapeutics Announces Science Translational Medicine Peer-Reviewed Publication Featuring GlyphAlloTM (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans

BOSTON--(BUSINESS WIRE)--Science Translational Medicine Features GlyphAlloTM: First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans.

Businesswire

via Businesswire

March 25, 2026 | 6:00 PM UTCUpdated 2h ago

Share Read original

Read the full article at Businesswire →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Businesswire

NewsDataAU

Comments

0 comments

Be respectful and constructive.

Loading comments...

Phosphorescent paint inspired Victorian-era Australians to dress up as ghosts and pull pranks

Science

Astronomers Spot Previously Unknown Space 'Cavity' That’s Quietly Protecting the Moon

Gizmodo-14h ago-1 sources

Science

Earth’s magnetic field may be more powerful than we thought

Scientificamerican-14h ago-1 sources

Science

Top climate scientist Kate Marvel just resigned from NASA. Here's why

Scientificamerican-14h ago-1 sources

Seaport Therapeutics Announces Science Translational Medicine Peer-Reviewed Publication Featuring GlyphAlloTM (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans

Source Verification

Comments

Phosphorescent paint inspired Victorian-era Australians to dress up as ghosts and pull pranks

Astronomers Spot Previously Unknown Space 'Cavity' That’s Quietly Protecting the Moon

Related Articles

Astronomers Spot Previously Unknown Space 'Cavity' That’s Quietly Protecting the Moon

Earth’s magnetic field may be more powerful than we thought

Top climate scientist Kate Marvel just resigned from NASA. Here's why